Log in

Relevant bibliographies by topics / Acute Bacterial Rhinosinusitis (ABRS) / Journal articles

To see the other types of publications on this topic, follow the link: Acute Bacterial Rhinosinusitis (ABRS).

Journal articles on the topic 'Acute Bacterial Rhinosinusitis (ABRS)'

Author: Grafiati

Published: 3 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Acute Bacterial Rhinosinusitis (ABRS).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Sabaru, Iulia, Codrut Sarafoleanu, and Alina Maria Borcan. "Evolution of microbial etiology in acute and chronic rhinosinusitis and its role in the current management of antibiotic treatment." Romanian Journal of Rhinology 8, no. 30 (2018): 87–94. http://dx.doi.org/10.2478/rjr-2018-0009.

Full text

Abstract:

Abstract BACKGROUND. Acute and chronic rhinosinusitis (CRS) are common conditions worldwide. In most cases, the etiology of acute rhinosinusitis (ARS) is viral, but there can be cases complicated by bacterial infection. The bacterial pathogens responsible for acute bacterial rhinosinusitis (ABRS) in most cases are Streptococcus pneumoniae, Haemophilus influenza and Moraxella catarrhalis. In recent years, some changes regarding this issue have been communicated. Also, the pathophysiology of CRS becomes a problem due to the increasing percentage of resistant or recurrent cases. OBJECTIVE. To ide

APA, Harvard, Vancouver, ISO, and other styles

2

Chakravorty, Sanyukta, and Sumit Sharma. "Effect of Seasonal Allergic Rhinitis on Nasal Microbiota and Its Effect on Etiopathogenesis of Sinusitis in Allergic Rhinitis." Galore International Journal of Health Sciences and Research 7, no. 2 (2022): 29–36. http://dx.doi.org/10.52403/gijhsr.20220405.

Full text

Abstract:

Introduction: Rhinosinusitis refers to an inflammatory condition involving the nasal sinuses. Sinusitis is a common condition, with between 24 and 31 million cases occurring in the United States annually. Microbes and allergens can stimulate the nasal mucosa, potentially leading to the development of acute bacterial rhinosinusitis (ABRS). This study is to be designed to determine if allergen exposure alters the sinonasal microbiome. Allergic rhinitis is considered a major risk factor for acute bacterial rhinosinusitis (ABRS). Aim and objective: To determine the change in normal nasal flora due

APA, Harvard, Vancouver, ISO, and other styles

3

Pshennikov, D. S., and I. B. Angotoeva. "Principles of drug therapy for acute bacterial rhinosinusitis: from evidence-based medicine to practice." I.P. Pavlov Russian Medical Biological Herald 26, no. 1 (2018): 106–16. http://dx.doi.org/10.23888/pavlovj20181106-116.

Full text

Abstract:

The problem of treatment of acute rhinosinusitis (ARS) is extremely important due to high prevalence of the disease. According to statistical data the ARS affects from 6% to 15% of population and does not show any tendency to reduction. These figures are associated with a high rate of acute respiratory viral infection (ARVI) which directly leads to rhinosinusitis. But, however, despite the fact that practically every individual experiences from 2 to 5 episodes of ARVI every year, only 0.5-2% of them are complicated with acute bacterial rhinosinusitis (ABRS). Despite this low percentage of bact

APA, Harvard, Vancouver, ISO, and other styles

4

Pshennikov, D. S., and I. B. Angotoeva. "Principles of drug therapy for acute bacterial rhinosinusitis: from evidence-based medicine to practice." I.P. Pavlov Russian Medical Biological Herald 26, no. 1 (2018): 106–16. http://dx.doi.org/10.23888/pavlovj2018261106-116.

Full text

Abstract:

The problem of treatment of acute rhinosinusitis (ARS) is extremely important due to high prevalence of the disease. According to statistical data the ARS affects from 6% to 15% of population and does not show any tendency to reduction. These figures are associated with a high rate of acute respiratory viral infection (ARVI) which directly leads to rhinosinusitis. But, however, despite the fact that practically every individual experiences from 2 to 5 episodes of ARVI every year, only 0.5-2% of them are complicated with acute bacterial rhinosinusitis (ABRS). Despite this low percentage of bact

APA, Harvard, Vancouver, ISO, and other styles

5

Perić, Aleksandar. "Acute rhinosinusitis: Pathogenesis, diagnosis and treatment." Galenika Medical Journal 1, no. 1 (2022): 72–77. http://dx.doi.org/10.5937/galmed2201072p.

Full text

Abstract:

Acute rhinosinusitis (ARS) is an inflammation of the mucous membranes of the nasal cavity and paranasal sinuses with symptoms lasting up to 12 weeks. In more than 98% cases, ARS begins as a viral infection with common cold symptoms, usually caused by rhinoviruses or more severe acute viral rhinosinusitis usually caused by coronaviruses, influenza and parainfluenza virus. Worsening of symptoms after 5 days or persistence of symptoms after 10 days indicate the diagnosis of acute postviral rhinosinusitis, which indicates the presence of bacterial superinfection on the basis of previous viral infe

APA, Harvard, Vancouver, ISO, and other styles

6

Cottrell, Justin, Jonathan Yip, Yvonne Chan, et al. "Quality Indicators for the Diagnosis and Management of Acute Bacterial Rhinosinusitis." American Journal of Rhinology & Allergy 34, no. 4 (2020): 519–31. http://dx.doi.org/10.1177/1945892420912158.

Full text

Abstract:

Background Acute bacterial rhinosinusitis (ABRS) is a highly prevalent disease that is treated by a variety of specialties, including but not limited to, family physicians, emergency physicians, otolaryngology—head and neck surgeons, infectious disease specialists, and allergy and immunologists. Unfortunately, despite high-quality guidelines, variable and substandard care continues to be demonstrated in the treatment of ABRS. Objective This study aimed to develop ABRS-specific quality indicators (QIs) to evaluate the diagnosis and management that reduces symptoms, improves quality of life, and

APA, Harvard, Vancouver, ISO, and other styles

7

Austin, Publishing Group. "Utility of Middle Meatus Cultures and Blood Cultures in the Management of Pediatric Patients with Acute Bacterial Rhinosinusitis Who Required Surgical Intervention." Austin Otolaryngology 12, no. 1 (2025): 1138. https://doi.org/10.26420/Austinjotolaryngol.2025.1138.

Full text

Abstract:

Abstract <strong>Introduction:</strong> Orbital and intracranial complications of acute bacterial rhinosinusitis (ABRS) in children relies on empiric and/or culture-directed antibiotics for treatment <strong>Objective:</strong> The goal of our study is to determine the reliability of preoperative cultures, including bedside Middle Meatus Cultures (MMCx) and Blood Cultures (BCx), and their correspondence to intraoperative sinus culture in children with orbital and intracranial complications of ABRS in children. <strong>Methods:</strong> We performed a retrospective review of pati

APA, Harvard, Vancouver, ISO, and other styles

8

Alghulikah, Abdulrahman, Sarah Alseneidi, Hedayah Alsaady, et al. "Abducens Nerve Neuropraxia due to Acute Bacterial Rhinosinusitis: Case Report and Literature Review." Case Reports in Otolaryngology 2023 (November 27, 2023): 1–7. http://dx.doi.org/10.1155/2023/5175871.

Full text

Abstract:

Background. Acute bacterial rhinosinusitis (ABRS) is a common infection of the paranasal sinuses that can lead to complications such as orbital and intracranial extension. The abducens nerve course is adjacent to the sphenoid sinus. Diplopia is rarely the initial presentation of sphenoid sinus pathology. In this article, we present the case of a middle-aged male who presented with diplopia and abducens nerve palsy secondary to ABRS, and we conducted a literature review in search of similar cases. Case Presentation. A 52-year-old male presented with diplopia secondary to ABRS. Imaging revealed

APA, Harvard, Vancouver, ISO, and other styles

9

Szaleniec, Gibała, Pobiega, et al. "Exacerbations of Chronic Rhinosinusitis—Microbiology and Perspectives of Phage Therapy." Antibiotics 8, no. 4 (2019): 175. http://dx.doi.org/10.3390/antibiotics8040175.

Full text

Abstract:

The chronically inflamed mucosa in patients with chronic rhinosinusitis (CRS) can additionally be infected by bacteria, which results in an acute exacerbation of the disease (AECRS). Currently, AECRS is universally treated with antibiotics following the guidelines for acute bacterial rhinosinusitis (ABRS), as our understanding of its microbiology is insufficient to establish specific treatment recommendations. Unfortunately, antibiotics frequently fail to control the symptoms of AECRS due to biofilm formation, disruption of the natural microbiota, and arising antibiotic resistance. These issue

APA, Harvard, Vancouver, ISO, and other styles

10

Starostina, S. V., and D. A. Sivokhin. "Systemic antibiotic therapy of patients with acute bacterial sinusitis taking into account resistance." Meditsinskiy sovet = Medical Council, no. 18 (December 1, 2021): 172–77. http://dx.doi.org/10.21518/2079-701x-2021-18-172-177.

Full text

Abstract:

Acute rhinosinusitis is one of the most common diseases in the world. According to statistics, about 10 million cases are registered in Russia every year.Acute bacterial rhinosinusitis (ABRS) in most cases develops as a result of an acute respiratory viral disease, proceeds easily and it does not require antibiotic therapy. However, it significantly reduces the patient's quality of life in cases of moderate and severe disease, and in the absence of timely treatment, can lead to intracranial complications (meningitis, encephalitis, intracranial abscesses, etc.) and orbital (reactive edema of th

APA, Harvard, Vancouver, ISO, and other styles

11

Ferguson, Berrylin J., Jack Anon, Michael D. Poole, Kim Hendrick, Martyn Gilson, and Elyse G. Seltzer. "Short Treatment Durations for Acute Bacterial Rhinosinusitis: Five Days of Gemifloxacin versus 7 Days of Gemifloxacin." Otolaryngology–Head and Neck Surgery 127, no. 1 (2002): 1–6. http://dx.doi.org/10.1067/mhn.2002.126593.

Full text

Abstract:

OBJECTIVE: The primary objective of this study was to demonstrate the clinical and radiologic efficacy of 5 days compared with 7 days of gemifloxacin therapy in the treatment of acute bacterial rhinosinusitis (ABRS). STUDY DESIGN: In this prospective, double-blind, multicenter, parallel-group study, adult patients presenting with ABRS were randomized to receive gemifloxacin 320 mg once daily for either 5 days (n = 218) or 7 days (n = 203). RESULTS: For the primary efficacy end point, clinical response to therapy at follow-up, 5 days of therapy with gemifloxacin was as effective as 7 days of th

APA, Harvard, Vancouver, ISO, and other styles

12

Stagniyeva, I. V., and P. A. Stateshnaya. "THE LATENT OF RHINOSINUSITIS AS A MANIFESTATION OF NEURO-IMMUNE INTERACTIONS." Medical academic journal 19, no. 1S (2019): 111–12. http://dx.doi.org/10.17816/maj191s1111-112.

Full text

Abstract:

Purpose: to determine the role of a pain symptom in the diagnosis of rhinosinusitis on the background of immune deficiency. 240 patients with rhinosinusitis without pain symptom were divided into 3 groups: group 1 - patients with acute viral rhinosinusitis (AVRS), group 2 - patients with acute bacterial sinusitis (ABRS), group 3 (n = 32) - control. All patients underwent a complete otorhinolaryngological examination, assessment of the pain symptom, an immunogram, the level of SP in the blood serum. At SP > 100 pg/ml in group 1, the change in indicators was typical for viral infection, in gr

APA, Harvard, Vancouver, ISO, and other styles

13

Dr., Ramsha Zulfiqar Dr. Nimra Ghazanfar Dr. Shumaila Malik. "A RANDOMISED CONTROLLED TRIAL TO FIND OUT THE BETTER TREATMENT CHOICE OF ACUTE BACTERIAL RHINOSINUSITIS." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 05, no. 09 (2018): 9254–60. https://doi.org/10.5281/zenodo.1439263.

Full text

Abstract:

<strong><em>Objective: </em></strong><em>The research objective is the comparison of the effectiveness of Levofloxacin and Amoxicillin-Clavulanate in the dealing of acute bacterial rhinosinusitis.</em> <strong><em>Materials & Methods: </em></strong><em>A sample size of 360 acute bacterial sinusitis patients of both genders, ageing from fifteen to fifty-five was selected. Those patients were excluded who had pneumonia, diabetes mellitus, and allergy to levofloxacin. Two random groups were made; Group A were given 01 gram, 02 times a day, of Amoxicillin-clavulanate for ten days and Group B w

APA, Harvard, Vancouver, ISO, and other styles

14

Byrjalsen, A., T. Ovesen, and T. Kjaergaard. "Staphylococcus aureus is a major pathogen in severe acute bacterial rhinosinusitis." Rhinology journal 52, no. 1 (2014): 48–52. http://dx.doi.org/10.4193/rhino13.004.

Full text

Abstract:

Purpose: The purpose of this study was to investigate the epidemiology and microbiology of severe acute bacterial rhinosinusitis in patients admitted to a Danish tertiary hospital. Methods: A retrospective study was performed including all cases of acute rhinosinusitis admitted to the ENT-department of Aarhus University Hospital, in the period 2001 to 2011. Results: In total, 143 cases of acute rhinosinusitis were identified of which 51% were children. The most prevalent bacterial strains were Staphylococcus aureus followed by group A streptococcus, Haemophilus influenzae and Streptococcus pne

APA, Harvard, Vancouver, ISO, and other styles

15

Wu, Pei-Wen, Yen-Ling Lin, Yun-Shien Lee, Cheng-Hsun Chiu, Ta-Jen Lee, and Chien-Chia Huang. "Predictors of Surgical Intervention for Pediatric Acute Rhinosinusitis with Periorbital Infection." Journal of Clinical Medicine 11, no. 13 (2022): 3831. http://dx.doi.org/10.3390/jcm11133831.

Full text

Abstract:

Background: Medical versus surgical management of pediatric periorbital infection secondary to acute bacterial rhinosinusitis (ABRS) can be a dilemma for clinicians. This study aimed to evaluate the prognostic factors related to the need for surgical drainage and to help direct management decisions. Methods: Children admitted for periorbital infection secondary to ABRS between 2001 and 2019 were retrospectively reviewed. Demographics, clinical presentations, laboratory data, comorbidities, and computed tomography results were collected from medical records. Results: A total of 141 pediatric pa

APA, Harvard, Vancouver, ISO, and other styles

16

Perić, Aleksandar, Dejan Gaćeša, Aleksandra Barać, Jelena Sotirović, and Aneta V. Perić. "Herbal Drug EPs 7630 versus Amoxicillin in Patients with Uncomplicated Acute Bacterial Rhinosinusitis: A Randomized, Open-Label Study." Annals of Otology, Rhinology & Laryngology 129, no. 10 (2020): 969–76. http://dx.doi.org/10.1177/0003489420918266.

Full text

Abstract:

Objective: Previous investigations suggest the use of extract from the root of Pelargonium sidoides (EPs 7630) for the therapy of uncomplicated acute upper airway inflammations, due to its strong antimicrobial and immunomodulatory effect. We aimed to compare clinical efficacy, safety and bactericidal effect of EPs 7630 and amoxicillin monotherapy in treatment of patients with mild to moderate acute bacterial rhinosinusitis (ABRS). Methods: Fifty ABRS patients were divided into two groups by randomization. Group 1 (n = 25) received EPs 7630 tablets, 3 × 20 mg/day per os for 10 days. Group 2 (n

APA, Harvard, Vancouver, ISO, and other styles

17

Wu, Derek, Jason Wasserman, and Marina Boruk. "Practice Patterns of Systemic Corticosteroid Use in Complicated Acute Rhinosinusitis Among Rhinologists and Pediatric Otolaryngologist." American Journal of Rhinology & Allergy 32, no. 6 (2018): 485–90. http://dx.doi.org/10.1177/1945892418797056.

Full text

Abstract:

Background The use of systemic corticosteroids remains controversial in the treatment of orbital complications of sinusitis. Objective To compare and contrast the current practice patterns of the use of systemic corticosteroid in the management of orbital complications of acute bacterial rhinosinusitis (ABRS) among fellowship-trained members of American Society of Pediatric Otolaryngology (ASPO) and American Rhinologic Society (ARS). Study Design Cross-sectional survey. Methods A web-based survey was electronically distributed to 497 members of ASPO and 845 members of ARS focusing on the pract

APA, Harvard, Vancouver, ISO, and other styles

18

Gorbunov, S. A., Yu Yu Rusetskii, S. E. Kudryashov, E. N. Pligina, and Yu S. Lapina. "Effectiveness of paranasal sinus drainage with nasal catheter in acute bacterial rhinosinusitis." Russian Otorhinolaryngology 21, no. 2 (2022): 16–23. http://dx.doi.org/10.18692/1810-4800-2022-2-16-23.

Full text

Abstract:

There are various ways to treat acute bacterial rhinosinusitis (ABRS), the main one being systemic antibiotic therapy (SAB), which seems logical today. However, the role of the method of active noninvasive drainage of the paranasal sinuses (PNS) with a nasal catheter (NC) in the treatment of this disease is not yet completely clear. Based on the pathogenesis of acute sinusitis, there are good reasons to use it as a possible treatment option. However, clinical studies are needed to confirm the effectiveness of the method. Objective. To evaluate the effectiveness of drainage of the paranasal sin

APA, Harvard, Vancouver, ISO, and other styles

19

Margaritis, Vasilios K., George S. Ismailos, Stefanos S. Naxakis, Nicholas S. Mastronikolis, and Panos D. Goumas. "Sinus Fluid Penetration of Oral Clarithromycin and Azithromycin in Patients with Acute Rhinosinusitis." American Journal of Rhinology 21, no. 5 (2007): 574–78. http://dx.doi.org/10.2500/ajr.2007.21.3071.

Full text

Abstract:

Background The aim of this study was to investigate the extracellular concentration and the degree of sinus fluid penetration of newer macrolides, within the first 24–48 hours of treatment in patients with acute bacterial rhinosinusitis (ABRS), choosing clarithromycin and azithromycin as model antibiotics. An open, noninterventional pharmacokinetic study was performed at a tertiary teaching hospital. Methods In 36 outpatients with ABRS, sinus fluid aspirates and serum samples were collected 2, 4, 6, 8, and 12 hours or 2, 6, 12, and 24 hours after the administration of three doses of oral clari

APA, Harvard, Vancouver, ISO, and other styles

20

Tran, Dang, Bonnie Westra, and Kevin Smith. "Sinusitis Treatment Guideline Adherence in the e-visit Setting." Applied Clinical Informatics 07, no. 02 (2016): 299–307. http://dx.doi.org/10.4338/aci-2015-10-cr-0143.

Full text

Abstract:

SummaryStudies demonstrate poor guideline adherence by health care providers for the treatment of upper respiratory infections, particularly acute bacterial rhinosinusitis (ABRS), in the appropriate prescribing of antibiotic medications.The purpose of this quality improvement project was to evaluate the effect of implementing interventions for improving adherence to a clinical practice guideline for the management of ABRS for patients treated in the e-visit setting. Interventions included: providing a report to providers of their adherence to the ABRS clinical guideline prior to the interventi

APA, Harvard, Vancouver, ISO, and other styles

21

Al Hariri, Mahmoud Joumaa, Ivanna V. Koshel, and Vasil I. Popovich. "Clinical and microbiological parallels of delayed prescribing of antibiotics in patients with acute rhinosinusitis." OTORHINOLARYNGOLOGY №5-6(3) 2020, no. 5-6(3) 2020 (November 4, 2020): 49–57. http://dx.doi.org/10.37219/2528-8253-2020-6-49.

Full text

Abstract:

Topicality: The rate of acute bacterial rhinosinusitisis 0,5-2% of all cases of acute rhinosinusitis, however, up to 60 % of patients receive the course of antibiotics since the first day of disease. It is well known that earlier use of antibiotics has almost no effect on the development of bacterial ARS and its complications. The purpose of study was to examine the bacterial spectrum of post-viral RS and evaluate clinical and bac-teriological efficiency of polyvalent bacteriophage in technique of delayed prescribing of antibiotics in comparison with the patients receiving standard APVRS thera

APA, Harvard, Vancouver, ISO, and other styles

22

Mękarska, Marta, Maria Molga-Magusiak, Tomasz Gotlib, Emilia Wnuk, and Kazimierz Niemczyk. "Intracranial abscess as a complication of acute bacterial sinusitis of odontogenic origin – a case report." Polski Przegląd Otorynolaryngologiczny 12, no. 4 (2023): 51–56. http://dx.doi.org/10.5604/01.3001.0054.0136.

Full text

Abstract:

<b><br>Introduction:</b> Odontogenic sinusitis (ODS) is an inflammatory process of bacterial etiology (most commonly associated with anaerobes), which may lead to life threatening complications such as intracranial abscess.</br> <b><br>Aim:</b> The aim was to discuss the stages of abscess formation as a rhinosinusitis complication, their pathology, as well as corresponding computed tomography (CT) and magnetic resonance imaging (MRI) images are presented, based on presented case report.</br> <b><br>Case report:</b> We described

APA, Harvard, Vancouver, ISO, and other styles

23

Dale, Ariella P., Christian Marchello, and Mark H. Ebell. "Clinical gestalt to diagnose pneumonia, sinusitis, and pharyngitis: a meta-analysis." British Journal of General Practice 69, no. 684 (2019): e444-e453. http://dx.doi.org/10.3399/bjgp19x704297.

Full text

Abstract:

BackgroundThe overall clinical impression (‘clinical gestalt’) is widely used for diagnosis but its accuracy has not been systematically studied.AimTo determine the accuracy of clinical gestalt for the diagnosis of community-acquired pneumonia (CAP), acute rhinosinusitis (ARS), acute bacterial rhinosinusitis (ABRS), and streptococcal pharyngitis, and to contrast it with the accuracy of clinical decision rules (CDRs).Design and settingSystematic review and meta-analysis of outpatient diagnostic accuracy studies in ambulatory care.MethodPubMed and Google were searched for studies in outpatients

APA, Harvard, Vancouver, ISO, and other styles

24

Stallworth, Christian L., K. Christopher McMains, and Frank Miller. "S131 – Complicated Community-Acquired MRSA Sinusitis: A Case Series." Otolaryngology–Head and Neck Surgery 139, no. 2_suppl (2008): P120—P121. http://dx.doi.org/10.1016/j.otohns.2008.05.304.

Full text

Abstract:

Objectives Participants should 1) understand the similarities and differences between nosocomial methicillin-resistant Staphylococcus aureus (MRSA) and its community-acquired counterpart (CA-MRSA); 2) recognize MRSA as an evolving member of the bacterial pathogens responsible for acute bacterial rhinosinusitis (ABRS); and 3) raise suspicion of CAMRSA in the differential for cases of progressive sinusitis, with or without complications, despite conventional first-line antimicrobial therapies. Methods Following the retrospective review of patients presenting to an urban tertiary care institution

APA, Harvard, Vancouver, ISO, and other styles

25

Аль Харири, М. Ж., В. И. Попович, and И. В. Кошель. "Possibility of Use of Bacteriophage in the Technique of Delayed Prescribing of Antibiotics in Patients with Acute Rhinosinusitis." Оториноларингология. Восточная Европа, no. 4 (February 12, 2021): 296–308. http://dx.doi.org/10.34883/pi.2020.10.4.045.

Full text

Abstract:

Введение. Острый риносинусит (ОРС) можно охарактеризовать как острый бактериальный риносинусит (ОБРС) только примерно в 0,5–5% случаев, поэтому не более 5% пациентов с ОРС требуют назначения антибактериальной терапии. Вместе с тем необоснованная антибактериальная терапия назначается в 54–77% случаев ОРС.Цель. Определить эффективность поливалентного бактериофага в технологии отложенного назначения антибиотиков у пациентов с острым поствирусным риносинуситом.Материалы и методы. В исследование включено 155 взрослых пациентов с острым послевирусным РС, получавших поливалентный бактериофаг дополнит

APA, Harvard, Vancouver, ISO, and other styles

26

Benninger, Micheal S., James A. Hadley, and J. David Osguthorpe. "Diagnosing Acute Bacterial Rhinosinusitis." Archives of Internal Medicine 164, no. 5 (2004): 568. http://dx.doi.org/10.1001/archinte.164.5.568-c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Wright, Wendy L. "Viral or Acute Bacterial Rhinosinusitis?" Nurse Practitioner 30, no. 5 (2005): 30–41. http://dx.doi.org/10.1097/00006205-200505000-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Conrad, Dennis A., and Hal B. Jenson. "Management of acute bacterial rhinosinusitis." Current Opinion in Pediatrics 14, no. 1 (2002): 86–90. http://dx.doi.org/10.1097/00008480-200202000-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

AGARWAL, ABHISHEK, ROBERT H. HOPKINS, and WILLIAM E. GOLDEN. "Acute Bacterial Rhinosinusitis in Adults." Internal Medicine News 45, no. 18 (2012): 24. http://dx.doi.org/10.1016/s1097-8690(12)70783-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Bucher, Heiner C., James Young, and Peter Tschudi. "Diagnosing Acute Bacterial Rhinosinusitis—Reply." Archives of Internal Medicine 164, no. 5 (2004): 568. http://dx.doi.org/10.1001/archinte.164.5.570-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Angotoeva, I. B., and D. S. Pshennikov. "The inhalation antibioticotherapy of acute bacterial rhinosinusitis." Medical Council, no. 20 (November 14, 2018): 50–54. http://dx.doi.org/10.21518/2079-701x-2018-20-50-54.

Full text

Abstract:

Epidemiological studies conducted throughout the world show that the inflammatory diseases of the nasal cavity and paranasal sinuses are the leading cause of otorhinolaryngology (ENT) hospital admissions and outpatient clinic referral. Although the most common cause of acute rhinosinusitis is viral infection, antibiotics are prescribed in more than 80% of cases, which may lead to the development of antimicrobial resistance. The topical inhalation therapy with the inhalation Complex «PARI SINUS device» (сompressor and nebulizer) may provide better treatment options for patients who suffer from

APA, Harvard, Vancouver, ISO, and other styles

32

Miah, M. S., P. Nix, A. Koukkoullis, and J. Sandoe. "Microbial causes of complicated acute bacterial rhinosinusitis and implications for empirical antimicrobial therapy." Journal of Laryngology & Otology 130, no. 2 (2015): 169–75. http://dx.doi.org/10.1017/s0022215115003369.

Full text

Abstract:

AbstractObjectives:Very little up-to-date information is available on the microbiology of complicated acute bacterial rhinosinusitis. Reliable microbiology testing is necessary to inform current empirical antimicrobial treatments. This study was conducted in response to recent US guidelines on antimicrobial treatments for acute bacterial rhinosinusitis. It aimed to describe the pathological micro-organisms involved in complicated acute bacterial rhinosinusitis in the UK and their antimicrobial susceptibility.Methods:This study collected retrospective data on cases of complicated acute bacteria

APA, Harvard, Vancouver, ISO, and other styles

33

Svistushkin, V. M., G. N. Nikiforova, and V. V. Lobacheva. "Rational Antibiotic Therapy in Patients with Bacterial Rhinosinusitis." Doctor.Ru 19, no. 11 (2020): 42–45. http://dx.doi.org/10.31550/1727-2378-2020-19-11-42-45.

Full text

Abstract:

Objective of the Paper: To demonstrate the significance of the rational use of antibiotics in management of patients with bacterial rhinosinusitis. Key Points. In the 21st century, bacterial infectious organisms are becoming more resistant and pose a global threat for the health care system, despite considerable achievements. The case study of acute bacterial rhinosinusitis demonstrates the role of the modern principles of rational antibiotic therapy prescribed by any medical professional. Conclusion. The case study supports the defining role of the rational causal treatment in efficient manag

APA, Harvard, Vancouver, ISO, and other styles

34

Rosenfeld, Richard M. "Clinical Practice Guideline on Adult Sinusitis." Otolaryngology–Head and Neck Surgery 137, no. 3 (2007): 365–77. http://dx.doi.org/10.1016/j.otohns.2007.07.021.

Full text

Abstract:

This executive summary will alert clinicians to key evidence-based statements in a multidisciplinary, clinical practice guideline on adult sinusitis developed by the American Academy of Otolaryngology–Head and Neck Surgery Foundation. Included in the guideline are 17 boldfaced action statements: 3 on viral rhinosinusitis, 7 on acute bacterial rhinosinusitis, and 7 on chronic rhinosinusitis and recurrent acute rhinosinusitis. Evidence profiles that accompany each statement are summarized to show why it was made and how it can be implemented. Guideline statements regarding acute rhinosinusitis f

APA, Harvard, Vancouver, ISO, and other styles

35

Dewi, Anna Mailasari Kusuma, and Desy Iriani. "Case Series : Orbital Complications In Pediatric Rhinosinusitis." Medica Hospitalia : Journal of Clinical Medicine 11, no. 1 (2024): 125–31. http://dx.doi.org/10.36408/mhjcm.v11i1.1073.

Full text

Abstract:

Introduction: Acute bacterial rhinosinusitis in children can cause orbital complications, either directly through fissures or indirectly through veins. Proper treatment can reduce morbidity due to orbital complications. Case: Two cases of orbital complications in pediatric acute bacterial rhinosinusitis caused by adenoid hypertrophy and dental infection. The first case of acute bacterial rhinosinusitis with periorbital cellulitis and left premaxillary abscess accompanied by adenoid hypertrophy and multiple pulp gangrene. The second case of acute bacterial rhinosinusitis with subperiosteal absc

APA, Harvard, Vancouver, ISO, and other styles

36

Woźniak, A., K. Nowak, J. Wnuk, et al. "Chronic rhinosinusitis: microbiology and treatment of acute exacerbations in patients after endoscopic surgery." Journal of Laryngology & Otology 135, no. 12 (2021): 1088–93. http://dx.doi.org/10.1017/s0022215121002759.

Full text

Abstract:

AbstractObjectiveAntibiotics are the mainstay of therapy for acute exacerbation of chronic rhinosinusitis. However, no treatment guidelines exist. Most clinicians follow the recommendations for acute bacterial rhinosinusitis, usually caused by Haemophilus influenzae, Streptococcus pneumoniae or Moraxella catarrhalis, and treat with amoxicillin or amoxicillin-clavulanate.MethodMedical data of 810 patients who had undergone endoscopic sinus surgery were analysed retrospectively. The results of bacterial cultures and treatment course were assessed in 152 patients who presented with acute exacerba

APA, Harvard, Vancouver, ISO, and other styles

37

Косаковский, А. Л. "Evaluation of Efficacy and Safety of Apicold Mint Nose Spray for Acute Viral and Bacterial Rhinosinusitis." Оториноларингология. Восточная Европа, no. 3 (November 11, 2021): 355–61. http://dx.doi.org/10.34883/pi.2021.11.3.024.

Full text

Abstract:

Введение. Острый риносинусит - одно из самых распространенных заболеваний среди детей и взрослых. Заболеваемость острым вирусным риносинуситом остается высокой. Особенно часто острым вирусным риносинуситом болеют дети школьного возраста. Цель. Оценка эффективности и безопасности применения Апиколд минт назальный спрей у детей и взрослых при остром вирусном и бактериальном риносинусите. Материалы и методы. В клиническое исследование было включено 165 пациентов, из них 123 (74,5%) с острым вирусным риносинуситом и 42 (25,5%) с острым бактериальным риносинуситом. Детей в возрасте от 4 до 18 лет б

APA, Harvard, Vancouver, ISO, and other styles

38

Krivopalov, A. A., and A. Р. Smirnov. "The use of roxithromycin in the treatment of acute bacterial rhinosinusitis." Medical Council, no. 21 (January 20, 2019): 61–65. http://dx.doi.org/10.21518/2079-701x-2018-21-61-65.

Full text

Abstract:

According to epidemiological studies, bacterial rhinosinusitis is one of the most common pathologies of ENT-organs on an upward trend. Rhinosinusitis significantly reduces the patient’s quality of life and, in the absence of timely treatment, can lead to serious complications. Macrolide antibiotics are effective drugs in the treatment of rhinosinusitis. Roxithromycin (Esparoxy), one of modern macrolides, showed good results. The article provides characteristics of this drug, reflects the high quality of efficacy and safety in the treatment of bacterial rhinosinusitis, with due regard to the ex

APA, Harvard, Vancouver, ISO, and other styles

39

Angotoeva, I. B., and D. S. Pshennikov. "The topical treatment of acute bacterial rhinosinusitis." Rossiiskaya rinologiya 25, no. 3 (2017): 46. http://dx.doi.org/10.17116/rosrino201725346-50.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Knoll, Christine. "Antimicrobial Treatment Guidelines for Acute Bacterial Rhinosinusitis." Clinical Pediatrics 40, no. 6 (2001): 359–60. http://dx.doi.org/10.1177/000992280104000612.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Bomer, Kelly, Alan Brichta, Fuad Baroody, Sue Boonlayangoor, Xiantang Li, and Robert M. Naclerio. "A Mouse Model of Acute Bacterial Rhinosinusitis." Archives of Otolaryngology–Head & Neck Surgery 124, no. 11 (1998): 1227. http://dx.doi.org/10.1001/archotol.124.11.1227.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Sher, Lawrence D., Michael D. Poole, Kristen Von Seggern, Matthew A. Wikler, Susan C. Nicholson, and George A. Pankey. "Community-Based Treatment of Acute Uncomplicated Bacterial Rhinosinusitis with Gatifloxacin." Otolaryngology–Head and Neck Surgery 127, no. 3 (2002): 182–89. http://dx.doi.org/10.1067/mhn.2002.127590.

Full text

Abstract:

OBJECTIVE: We sought to evaluate gatifloxacin in adults with acute uncomplicated bacterial rhinosinusitis. STUDY DESIGN: TeqCES was an open-label, multicenter, noncomparative study of the safety and efficacy of gatifloxacin. More than 11,000 adult patients with acute uncomplicated rhinosinusitis received gatifloxacin 400 mg once daily for 10 days. RESULTS: Moraxella catarrhalis (91% β-lactamase producers), Haemophilus influenzae (28% β-lactamase producers), Streptococcus pneumoniae (18% intermediately resistant and 14% fully resistant to penicillin), and Staphylococcus aureus were the predomin

APA, Harvard, Vancouver, ISO, and other styles

43

Khushvakova, Nilufar Jurakulovna, Sherali Jurabek ugli Turaev, and Mirmuhammad Xolboyevich Sanginov. "ACUTE AND CHRONIC RHINOSINUSITIS." SCHOLAR 2, no. 1 (2024): 238–42. https://doi.org/10.5281/zenodo.10480892.

Full text

Abstract:

<em>Acute sinusitis (ARS) and chronic rhinosinusitis (CRS) is a common condition worldwide. CRS is due to the infection and inflammation of paranasal sinuses. Frequent clinical manifestations of ARS include persistent symptoms with nasal discharge or cough or both, presentation with fever accompanies purulent nasal discharge, and worsening symptoms. Complications of CRS have five stages, preseptal cellulitis, orbital cellulitis, subperiosteal abscess, orbital abscess and cavernous sinus septic thrombosis. Most acute sinusitis generally of viral origin, e,g. rhinoviruses, corona viruses, and in

APA, Harvard, Vancouver, ISO, and other styles

44

Khushvakova, Nilufar Jurakulovna, Nilufar Ravshanovna Ruzikulova, and Sherali Jurabek ugli Turaev. "ACUTE AND CHRONIC RHINOSINUSITIS." Innovative Development in Educational Activities 3, no. 3 (2024): 331–34. https://doi.org/10.5281/zenodo.10666875.

Full text

Abstract:

<em>Acute sinusitis (ARS) and chronic rhinosinusitis (CRS) is a common condition worldwide. CRS is due to the infection and inflammation of paranasal sinuses. Frequent clinical manifestations of ARS include persistent symptoms with nasal discharge or cough or both, presentation with fever accompanies purulent nasal discharge, and worsening symptoms. Complications of CRS have five stages, preseptal cellulitis, orbital cellulitis, subperiosteal abscess, orbital abscess and cavernous sinus septic thrombosis. Most acute sinusitis generally of viral origin, e,g. rhinoviruses, corona viruses, and in

APA, Harvard, Vancouver, ISO, and other styles

45

Krivopalov, A. A., S. V. Ryazantsev, and V. V. Turieva. "Local treatment of acute rhinosinusitis in the era of COVID-19." Meditsinskiy sovet = Medical Council, no. 20 (November 15, 2022): 53–63. http://dx.doi.org/10.21518/2079-701x-2022-16-20-53-63.

Full text

Abstract:

Introduction. Acute rhinosinusitis accounts for 40 % to 60 % of the morbidity in the structure of ENT pathology. COVID-19 pathogen, similarly to other respiratory viruses, can cause acute rhinosinusitis, which is the most relevant at the present time due to the ongoing pandemic. Viral etiology accounts for 90–98 % of all cases of acute rhinosinusitis. Accordingly, the choice of treatment tactics with antibacterial drugs in a number of cases is unreasonable and leads to the growth of antibiotic resistance. Local antiseptics containing sodium hypochlorite with a high safety profile that do not c

APA, Harvard, Vancouver, ISO, and other styles

46

Ryazantsev, S. V., A. A. Krivopalov, P. A. Shamkina, and K. A. Lezhneva. "Highlights of prescribing herbal medicines in the complex therapy of acute rhinosinusitis." Meditsinskiy sovet = Medical Council, no. 16 (November 14, 2020): 18–25. http://dx.doi.org/10.21518/2079-701x-2020-16-18-25.

Full text

Abstract:

Today, acute rhinosinusitis is one of the most common infectious diseases in the world. Usually, acute rhinosinusitis develops against the background of acute respiratory viral infection caused by influenza viruses, parainfluenza, respiratory syncytial virus, adenoviruses, or rhinoviruses. At the same time, in 1–2% of cases, the course of acute respiratory viral infection is complicated by bacterial sinusitis. At the same time, in 1–2% of cases, the course of acute respiratory viral infection is complicated by bacterial sinusitis. Considering the stages of the process, it is extremely importan

APA, Harvard, Vancouver, ISO, and other styles

47

1., Nurov U.I. 2. Khazratov O.R. 3. Rashidov D.R. "THE INCIDENCE OF RHINOSINUSITIS AMONG ENT DISEASES IN SCHOOL-AGE CHILDREN." zamonaviy dunyoda innovatsion tadqiqotlar 2, no. 6 (2023): 70–71. https://doi.org/10.5281/zenodo.7638821.

Full text

Abstract:

According to American researchers, 4.6% of all visits to a general practitioner are for cases of rhinosinusitis. Acute bacterial rhinosinusitis is the 5th most common antibiotic prescription in children [1,3]. Each child suffers acute respiratory viral infections (ARVI) up to 6-8 times a year, which are often complicated by rhinosinusitis

APA, Harvard, Vancouver, ISO, and other styles

48

Ebell, Mark H., Brian McKay, Ariella Dale, Ryan Guilbault, and Yokabed Ermias. "Accuracy of Signs and Symptoms for the Diagnosis of Acute Rhinosinusitis and Acute Bacterial Rhinosinusitis." Annals of Family Medicine 17, no. 2 (2019): 164–72. http://dx.doi.org/10.1370/afm.2354.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Starostina, Svetlana V., and Dmitrii A. Sivokhin. "Topical therapy in the treatment of patients with acute rhinosinusitis in adults." Consilium Medicum 23, no. 3 (2021): 210–15. http://dx.doi.org/10.26442/20751753.2021.3.200829.

Full text

Abstract:

Acute rhinosinusitis is one of the most common diseases in the world, characterized by acute inflammatory processes in the nasal cavity and paranasal sinuses, lasting less than 4 weeks. According to statistics, in Russia, this disease is recorded in 6–15% of the population annually, in European countries in every seventh person, while there is a tendency to an increase in the incidence. Acute viral rhinosinusitis has the highest incidence among all rhinosinusitis and occurs in most patients in a mild form, however, untimely treatment of inflammation of the nasal mucosa can lead to obstruction

APA, Harvard, Vancouver, ISO, and other styles

50

Esposito, S., and N. Principi. "Rhinosinusitis Management in Pediatrics: An Overview." International Journal of Immunopathology and Pharmacology 23, no. 1_suppl (2010): 53–55. http://dx.doi.org/10.1177/03946320100230s114.

Full text

Abstract:

Rhinosinusitis is an inflammation of one or more paranasal sinuses, usually caused by an infection. The clinical appearance of rhinosinusitis may be heterogeneous and change with patient age, the duration of symptoms and, above all, the seriousness of the illness. The diagnosis of rhinosinusitis should only be based on anamnestic and clinical criteria in children with serious or persistent symptoms of upper respiratory tract infection, or which appear within a short time of an apparent recovery. Imaging studies are not usually necessary to confirm a diagnosis of uncomplicated acute bacterial r

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!